Agilent Technologies, Inc. (A) vs Natera, Inc. (NTRA)

Agilent Technologies, Inc. and Natera, Inc. are both Diagnostics & Research companies. Agilent Technologies, Inc. and Natera, Inc. are of similar size ($52.4B and $48.4B). Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Agilent Technologies, Inc. trades at 33.8×. Natera, Inc. grew revenue faster over the last twelve months: 37.4% against 8.60%. Agilent Technologies, Inc. has the higher net margin (19.5% vs −5.66%) and the higher return on invested capital (11.1% vs −8.35%). Across the 20 metrics below, Agilent Technologies, Inc. leads on 16 and Natera, Inc. on 4.

Valuation

Metric A NTRA Diagnostics & Research median
P/E 33.77 n/m 34.52
P/S 6.58 18.12 4.24
P/B 6.58 28.19 3.42
Price to free cash flow 38.20 1,004.35 33.51
EV/EBITDA 26.37 n/m 23.44
EV/Sales 6.83 17.87 5.18
Earnings yield 2.96% (0.31%) (1.50%)
Free cash flow yield 2.62% 0.10% 0.00%

Profitability

Metric A NTRA Diagnostics & Research median
Gross margin 53.83% 0.00% 48.32%
Operating margin 22.23% (8.95%) (5.68%)
Net margin 19.53% (5.66%) (4.10%)
Free cash flow margin 17.19% 1.80% 0.00%
Return on equity 20.97% (10.55%) 0.00%
Return on assets 11.00% (7.21%) (6.05%)
Return on invested capital 11.07% (8.35%) 0.00%

Growth

Metric A NTRA Diagnostics & Research median
Revenue growth (TTM) 8.60% 37.43% 8.99%
EPS growth (last fiscal year) 3.16% 0.65% 20.36%
Revenue growth, 5-year CAGR 5.41% 42.61% 7.30%
Net income growth, 5-year CAGR 12.63% 0.00% 0.00%

Health

Metric A NTRA Diagnostics & Research median
Debt to equity 0.50 0.04 0.01
Current ratio 2.05 2.81 2.27
Net debt to EBITDA 0.71 3.74 0.68

Dividend

Metric A NTRA Diagnostics & Research median
Dividend yield 0.59% — 0.67%
Payout ratio 0.20 — 0.20

Size

Metric A NTRA Diagnostics & Research median
Market cap 48.43b 52.43b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack